Retinitis pigmentosa and nanophthalmos in a patient with attenuated Hunter’s syndrome
Purpose To describe a case of retinitis pigmentosa and nanophthalmos in a patient with attenuated Hunter’s syndrome. Methods Fundus photography, total field electroretinogram, ultrasound, computerized visual field examination, biochemical examination and genetic testing were obtained. Results The fu...
Gespeichert in:
Veröffentlicht in: | Documenta ophthalmologica 2023-06, Vol.146 (3), p.273-279 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
To describe a case of retinitis pigmentosa and nanophthalmos in a patient with attenuated Hunter’s syndrome.
Methods
Fundus photography, total field electroretinogram, ultrasound, computerized visual field examination, biochemical examination and genetic testing were obtained.
Results
The fundus exam showed diffuse arteriolar attenuation, optic disc with regular contours, and pigment agglomerates like "bone spicules" in the middle periphery
.
Ultrasound examination revealed scleral thickening and short axial diameter in both eyes. The total field electroretinogram exam showed a subnormal result with greater impairment of the scotopic phase of the exam. Computerized visual field examination demonstrated a diffuse reduction in retinal sensitivity in the periphery. Biochemical examination showed increased urine glycosaminoglycan excretion and iduronate-2-sulphatase activity (IDS) deficiency in leukocytes, confirming the type II mucopolysaccharidosis. Molecular analysis revealed a novel missense mutation (p.A77D) in the IDS gene.
Conclusion
The case report is about a patient presented an attenuated form of the syndrome, with no cognitive impairment. Ophthalmologic follow-up is still an important part of multidisciplinary treatment for Hunter’s syndrome. |
---|---|
ISSN: | 0012-4486 1573-2622 |
DOI: | 10.1007/s10633-023-09924-z |